John D. Loike and Alan Kadish | Jun 14, 2018 | 4 min read
The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.
John Robertson was known for his contributions to reproductive medicine ethics and for solidifying the scholarly connection between biomedicine and law.
The country’s fertility regulator has approved the first application to carry out mitochondrial replacement therapy, which uses biological material from two women and one man to create an embryo.
Differences in the replicative advantages conferred by some mitochondrial DNA haplotypes have implications for mitochondrial replacement therapy, researchers report.